LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 3 of 15: Cell count and relative growth within biological replicate 3. - Dataset (ID:20239)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Relative Growth Rate After Treatment |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | Pictilisib | 1.11 | uM | LJP6 | 3 | D21 | 72 | hr | 1401 | 1680 | 4223 | 0.3978 | 0.0987 |
| SK-BR-3 | Gefitinib | 1.11 | uM | LJP6 | 1 | N09 | 72 | hr | 1401 | 2721 | 4223 | 0.6443 | 0.4676 |
| SK-BR-3 | Gefitinib | 1.11 | uM | LJP6 | 2 | N09 | 72 | hr | 1401 | 2710 | 4223 | 0.6417 | 0.4637 |
| SK-BR-3 | Gefitinib | 1.11 | uM | LJP6 | 3 | N09 | 72 | hr | 1401 | 2795 | 4223 | 0.6618 | 0.4939 |
| SK-BR-3 | Geldanamycin | 1.11 | uM | LJP5 | 1 | O03 | 72 | hr | 1401 | 1111 | 4223 | 0.2631 | -0.1030 |
| SK-BR-3 | Geldanamycin | 1.11 | uM | LJP5 | 2 | O03 | 72 | hr | 1401 | 1571 | 4223 | 0.3720 | 0.0601 |
| SK-BR-3 | Geldanamycin | 1.11 | uM | LJP5 | 3 | O03 | 72 | hr | 1401 | 1393 | 4223 | 0.3299 | -0.0030 |
| SK-BR-3 | Geldanamycin | 1.11 | uM | LJP6 | 1 | O03 | 72 | hr | 1401 | 1573 | 4223 | 0.3725 | 0.0608 |
| SK-BR-3 | Geldanamycin | 1.11 | uM | LJP6 | 2 | O03 | 72 | hr | 1401 | 1357 | 4223 | 0.3213 | -0.0158 |
| SK-BR-3 | Geldanamycin | 1.11 | uM | LJP6 | 3 | O03 | 72 | hr | 1401 | 1331 | 4223 | 0.3152 | -0.0250 |
| SK-BR-3 | GSK1059615 | 1.11 | uM | LJP5 | 1 | E03 | 72 | hr | 1401 | 1455 | 4223 | 0.3445 | 0.0190 |
| SK-BR-3 | GSK1059615 | 1.11 | uM | LJP5 | 2 | E03 | 72 | hr | 1401 | 1794 | 4223 | 0.4248 | 0.1391 |
| SK-BR-3 | GSK1059615 | 1.11 | uM | LJP5 | 3 | E03 | 72 | hr | 1401 | 1979 | 4223 | 0.4686 | 0.2047 |
| SK-BR-3 | GSK1059615 | 1.11 | uM | LJP6 | 1 | C03 | 72 | hr | 1401 | 1619 | 4223 | 0.3834 | 0.0771 |
| SK-BR-3 | GSK1059615 | 1.11 | uM | LJP6 | 2 | C03 | 72 | hr | 1401 | 1687 | 4223 | 0.3995 | 0.1012 |
| SK-BR-3 | GSK1059615 | 1.11 | uM | LJP6 | 3 | C03 | 72 | hr | 1401 | 1719 | 4223 | 0.4071 | 0.1125 |
| SK-BR-3 | GSK1904529A | 1.11 | uM | LJP6 | 1 | H21 | 72 | hr | 1401 | 4116 | 4223 | 0.9746 | 0.9621 |
| SK-BR-3 | GSK1904529A | 1.11 | uM | LJP6 | 2 | H21 | 72 | hr | 1401 | 4047 | 4223 | 0.9583 | 0.9376 |
| SK-BR-3 | GSK1904529A | 1.11 | uM | LJP6 | 3 | H21 | 72 | hr | 1401 | 4177 | 4223 | 0.9891 | 0.9837 |
| SK-BR-3 | Omipalisib | 1.11 | uM | LJP6 | 1 | N03 | 72 | hr | 1401 | 1133 | 4223 | 0.2683 | -0.0952 |
| SK-BR-3 | Omipalisib | 1.11 | uM | LJP6 | 2 | N03 | 72 | hr | 1401 | 1054 | 4223 | 0.2496 | -0.1232 |
| SK-BR-3 | Omipalisib | 1.11 | uM | LJP6 | 3 | N03 | 72 | hr | 1401 | 1191 | 4223 | 0.2820 | -0.0746 |
| SK-BR-3 | GSK 690693 | 1.11 | uM | LJP5 | 1 | F21 | 72 | hr | 1401 | 2822 | 4223 | 0.6682 | 0.5034 |
| SK-BR-3 | GSK 690693 | 1.11 | uM | LJP5 | 2 | F21 | 72 | hr | 1401 | 2931 | 4223 | 0.6940 | 0.5421 |
| SK-BR-3 | GSK 690693 | 1.11 | uM | LJP5 | 3 | F21 | 72 | hr | 1401 | 3017 | 4223 | 0.7144 | 0.5726 |